A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)
Stopped Due to company's assessment of enrollment feasibility.
Conditions
- Intrahepatic Cholestasis of Pregnancy
Interventions
- DRUG: Volixibat
- DRUG: Placebo
Sponsor
Mirum Pharmaceuticals, Inc.